Cart
sales@molnova.com
Pseudolaric Acid B
CAS No. 82508-31-4
Pseudolaric Acid B( PAB )
Catalog No. M16063 CAS No. 82508-31-4
Extracted from Pseudolarix kaempferi Gord. dry root barks or barks near the root;Store the product in sealed, cool and dry condition
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 66 | In Stock |
|
| 5MG | 106 | In Stock |
|
| 10MG | 179 | In Stock |
|
| 25MG | 390 | In Stock |
|
| 50MG | 546 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePseudolaric Acid B
-
NoteResearch use only, not for human use.
-
Brief DescriptionExtracted from Pseudolarix kaempferi Gord. dry root barks or barks near the root;Store the product in sealed, cool and dry condition
-
DescriptionExtracted from Pseudolarix kaempferi Gord. dry root barks or barks near the root;Store the product in sealed, cool and dry condition.
-
In Vitro——
-
In Vivo——
-
SynonymsPAB
-
PathwayMAPK/ERK Signaling
-
Targetp38 MAPK
-
Recptorp38
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number82508-31-4
-
Formula Weight432.18
-
Molecular FormulaC23H28O8
-
Purity>98% (HPLC)
-
SolubilityDMSO: 10 mM
-
SMILESO=C(O)/C(C)=C/C=C/[C@](O1)(C)[C@]2([H])[C@@]3(OC(C)=O)CCC(C(OC)=O)=CC[C@@](CC2)3C1=O
-
Chemical Name(2E,4E)-5-((3R,4R,4aS,9aS)-4a-acetoxy-7-(methoxycarbonyl)-3-methyl-1-oxo-3,4,4a,5,6,9-hexahydro-1H-4,9a-ethanocyclohepta[c]pyran-3-yl)-2-methylpenta-2,4-dienoic acid
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Li T, et al. Life Sci. 2015 Jan 15;121:88-96.
molnova catalog
related products
-
Losmapimod
Losmapimod (GSK-AHAB, GW856553X, SB856553)?is a selective, potent, orally active p38 MAPK inhibitor with pKi of 8.1 and 7.6 for p38α and p38β, respectively.
-
PH797804
PH-797804 is a novel pyridinone inhibitor of p38α with IC50 of 26 nM in a cell-free assay; 4-fold more selective versus p38β and does not inhibit JNK2. Phase 2.
-
BI-2865
BI-2865 is a none-covalent pan-KRAS Inhibitor. BI-2865 binds to WT, G12C, G12D, G12V and G13D mutant KRAS with KDs of 6.9, 4.5, 32, 26, 4.3 nM respectively.
